Therapeutic effect of astaxanthin isolated from Xanthophyllomyces dendrorhous mutant against naproxen-induced gastric antral ulceration in rats

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Frequently used for humans as a nonsteroidal anti-inflammatory drug, naproxen has been known to induce ulcerative gastric lesions. The present study was undertaken to investigate the in vivo therapeutic effect of astaxanthin, isolated from a Xanthophyllomyces dendrorhous mutant, against naproxen-induced gastric antral ulceration in rats. The rats were treated with three doses of astaxanthin [1, 5, and 25 mg/kg body weight (B.W.), respectively] once daily for 2 weeks after pretreatment of 80 mg of naproxen/kg B.W. twice daily for 3 days, while the control rats received only 80 mg of naproxen/kg B.W. twice daily for 3 days. The oral administration of astaxanthin (1, 5, and 25 mg/kg B.W.) showed a curative effect against naproxen (80 mg/kg B.W.)-induced gastric antral ulcer and reduced the elevated lipid peroxide level in gastric mucosa. In addition, astaxanthin treatment resulted in significant increase in the activities of radical scavenging enzymes such as superoxide dismutase, catalase, and glutathione peroxidase. A histologic examination clearly proved that acute gastric mucosal lesion induced by naproxen nearly disappeared after the astaxanthin treatment. These results suggest that astaxanthin eliminated the lipid peroxides and free radicals induced by naproxen and may be a potential candidate for remedy of gastric ulceration.

Original languageEnglish
Pages (from-to)633-639
Number of pages7
JournalJournal of Microbiology and Biotechnology
Volume15
Issue number3
Publication statusPublished - 2005 Jun 1

Fingerprint

Naproxen
Therapeutic Uses
Rats
Stomach
Rat control
Scavenging
Body Weight
Free radicals
Enzymes
Lipid Peroxides
Stomach Ulcer
Glutathione Peroxidase
Gastric Mucosa
astaxanthine
Antral
Catalase
Superoxide Dismutase
Free Radicals
Oral Administration
Anti-Inflammatory Agents

Keywords

  • Anti-ulcer drug
  • Astaxanthin
  • Gastric antral ulceration
  • Orogastric administration
  • Xanthophyllomyces dendrorhous

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology
  • Microbiology
  • Bioengineering

Cite this

@article{667d82c6f9dc4ea3a361e4f04632434f,
title = "Therapeutic effect of astaxanthin isolated from Xanthophyllomyces dendrorhous mutant against naproxen-induced gastric antral ulceration in rats",
abstract = "Frequently used for humans as a nonsteroidal anti-inflammatory drug, naproxen has been known to induce ulcerative gastric lesions. The present study was undertaken to investigate the in vivo therapeutic effect of astaxanthin, isolated from a Xanthophyllomyces dendrorhous mutant, against naproxen-induced gastric antral ulceration in rats. The rats were treated with three doses of astaxanthin [1, 5, and 25 mg/kg body weight (B.W.), respectively] once daily for 2 weeks after pretreatment of 80 mg of naproxen/kg B.W. twice daily for 3 days, while the control rats received only 80 mg of naproxen/kg B.W. twice daily for 3 days. The oral administration of astaxanthin (1, 5, and 25 mg/kg B.W.) showed a curative effect against naproxen (80 mg/kg B.W.)-induced gastric antral ulcer and reduced the elevated lipid peroxide level in gastric mucosa. In addition, astaxanthin treatment resulted in significant increase in the activities of radical scavenging enzymes such as superoxide dismutase, catalase, and glutathione peroxidase. A histologic examination clearly proved that acute gastric mucosal lesion induced by naproxen nearly disappeared after the astaxanthin treatment. These results suggest that astaxanthin eliminated the lipid peroxides and free radicals induced by naproxen and may be a potential candidate for remedy of gastric ulceration.",
keywords = "Anti-ulcer drug, Astaxanthin, Gastric antral ulceration, Orogastric administration, Xanthophyllomyces dendrorhous",
author = "Kim, {Jeong Hwan} and Kim, {Seung Wook} and Cheol-Won Yun and Hyo-Ihl Chang",
year = "2005",
month = "6",
day = "1",
language = "English",
volume = "15",
pages = "633--639",
journal = "Journal of Microbiology and Biotechnology",
issn = "1017-7825",
publisher = "Korean Society for Microbiolog and Biotechnology",
number = "3",

}

TY - JOUR

T1 - Therapeutic effect of astaxanthin isolated from Xanthophyllomyces dendrorhous mutant against naproxen-induced gastric antral ulceration in rats

AU - Kim, Jeong Hwan

AU - Kim, Seung Wook

AU - Yun, Cheol-Won

AU - Chang, Hyo-Ihl

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Frequently used for humans as a nonsteroidal anti-inflammatory drug, naproxen has been known to induce ulcerative gastric lesions. The present study was undertaken to investigate the in vivo therapeutic effect of astaxanthin, isolated from a Xanthophyllomyces dendrorhous mutant, against naproxen-induced gastric antral ulceration in rats. The rats were treated with three doses of astaxanthin [1, 5, and 25 mg/kg body weight (B.W.), respectively] once daily for 2 weeks after pretreatment of 80 mg of naproxen/kg B.W. twice daily for 3 days, while the control rats received only 80 mg of naproxen/kg B.W. twice daily for 3 days. The oral administration of astaxanthin (1, 5, and 25 mg/kg B.W.) showed a curative effect against naproxen (80 mg/kg B.W.)-induced gastric antral ulcer and reduced the elevated lipid peroxide level in gastric mucosa. In addition, astaxanthin treatment resulted in significant increase in the activities of radical scavenging enzymes such as superoxide dismutase, catalase, and glutathione peroxidase. A histologic examination clearly proved that acute gastric mucosal lesion induced by naproxen nearly disappeared after the astaxanthin treatment. These results suggest that astaxanthin eliminated the lipid peroxides and free radicals induced by naproxen and may be a potential candidate for remedy of gastric ulceration.

AB - Frequently used for humans as a nonsteroidal anti-inflammatory drug, naproxen has been known to induce ulcerative gastric lesions. The present study was undertaken to investigate the in vivo therapeutic effect of astaxanthin, isolated from a Xanthophyllomyces dendrorhous mutant, against naproxen-induced gastric antral ulceration in rats. The rats were treated with three doses of astaxanthin [1, 5, and 25 mg/kg body weight (B.W.), respectively] once daily for 2 weeks after pretreatment of 80 mg of naproxen/kg B.W. twice daily for 3 days, while the control rats received only 80 mg of naproxen/kg B.W. twice daily for 3 days. The oral administration of astaxanthin (1, 5, and 25 mg/kg B.W.) showed a curative effect against naproxen (80 mg/kg B.W.)-induced gastric antral ulcer and reduced the elevated lipid peroxide level in gastric mucosa. In addition, astaxanthin treatment resulted in significant increase in the activities of radical scavenging enzymes such as superoxide dismutase, catalase, and glutathione peroxidase. A histologic examination clearly proved that acute gastric mucosal lesion induced by naproxen nearly disappeared after the astaxanthin treatment. These results suggest that astaxanthin eliminated the lipid peroxides and free radicals induced by naproxen and may be a potential candidate for remedy of gastric ulceration.

KW - Anti-ulcer drug

KW - Astaxanthin

KW - Gastric antral ulceration

KW - Orogastric administration

KW - Xanthophyllomyces dendrorhous

UR - http://www.scopus.com/inward/record.url?scp=22544447065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22544447065&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:22544447065

VL - 15

SP - 633

EP - 639

JO - Journal of Microbiology and Biotechnology

JF - Journal of Microbiology and Biotechnology

SN - 1017-7825

IS - 3

ER -